We are live on ! Find out more
CELU icon

Celularity
CELU

73 hedge funds and large institutions have $44.3M invested in Celularity in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,568% more call options, than puts

Call options by funds: $1.07M | Put options by funds: $40K

56% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 16

13% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 15

1% more funds holding

Funds holding: 72 → 73 (+1)

0.1% less ownership

Funds ownership: 2.46% → 2.36% (-0.1%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

45% less capital invested

Capital invested by funds: $81.1M → $44.3M (-$36.8M)

Holders
73
Holders Change
+1
Holders Change %
+1.39%
% of All Funds
1.17%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
17
Increased
25
Reduced
16
Closed
15
Calls
$1.07M
Puts
$40K
Net Calls
+$1.03M
Net Calls Change
-$1.66M

Top Buyers

1
State Street
State Street
Massachusetts
+$375K
2
BlackRock
BlackRock
New York
+$254K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$140K
4
BFO
Biltmore Family Office
North Carolina
+$106K
5
Swiss National Bank
Swiss National Bank
Switzerland
+$102K

Top Sellers

1
BRF
B. Riley Financial
California
-$870K
2
Millennium Management
Millennium Management
New York
-$433K
3
VIA
Vident Investment Advisory
Georgia
-$345K
4
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$127K
5
AQR Capital Management
AQR Capital Management
Connecticut
-$79K
Name Holding Trade Value Shares
Change 		Change in
Stake
HWA
51
HCR Wealth Advisors
California
$15.5K +$22.1K +1,200 New
Millennium Management
52
Millennium Management
New York
$15K -$433K -23,468 -95%
T. Rowe Price Associates
53
T. Rowe Price Associates
Maryland
$14K +$1.77K +96 +9%
Squarepoint
54
Squarepoint
New York
$13.2K +$18.8K +1,022 New
Wells Fargo
55
Wells Fargo
California
$13K -$2.01K -109 -10%
AB
56
Amalgamated Bank
New York
$13K – – –
CSS
57
Cubist Systematic Strategies
Connecticut
$10.7K -$35.2K -1,909 -70%
HWM
58
HighMark Wealth Management
Minnesota
$9.96K +$6.08K +330 +75%
PMEF
59
Point72 Middle East FZE
United Arab Emirates
$7.74K +$11.1K +600 New
AIP
60
Ameritas Investment Partners
Nebraska
$5.54K – – –
Simplex Trading
61
Simplex Trading
Illinois
$4K +$5.9K +320 New
TFM
62
TFC Financial Management
Massachusetts
$3.1K – – –
Citigroup
63
Citigroup
New York
$2.62K +$590 +32 +19%
FP
64
Financial Perspectives
Minnesota
$2.21K – – –
Fidelity Investments
65
Fidelity Investments
Massachusetts
$1.55K +$1.16K +63 +111%
BCA
66
Bray Capital Advisors
Florida
$1.29K – – –
CSPIA
67
Cary Street Partners Investment Advisory
Virginia
$1.29K +$1.84K +100 New
MFG
68
Mendota Financial Group
Wisconsin
$1.29K +$1.84K +100 New
PNC Financial Services Group
69
PNC Financial Services Group
Pennsylvania
$1.29K +$1.84K +100 New
Osaic Holdings
70
Osaic Holdings
Arizona
$1K – – –
VNA
71
Valley National Advisers
Pennsylvania
$1K – – –
GEA
72
Glen Eagle Advisors
New Jersey
$148 – – –
BRF
73
B. Riley Financial
California
– -$870K -37,682 Closed
VIA
74
Vident Investment Advisory
Georgia
– -$345K -14,930 Closed
Tudor Investment Corp
75
Tudor Investment Corp
Connecticut
– -$127K -5,479 Closed
1 2
3
4

CELU Hedge Fund Activity: Q4 2022 in Review

73 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q4 2022, worth a combined $44.3M — down 45% from $81.1M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new CELU positions and 15 closed out — a net gain of 2 holders — while 25 added to existing stakes and 16 trimmed.

The largest buyer was State Street, adding an estimated $375K. The largest seller was B. Riley Financial, exiting entirely with an estimated $870K sold.

  • 73 institutional investors held Celularity (CELU) as of Q4 2022, up from 72 in Q3 2022.
  • Funds reported $44.3M of Celularity stock for Q4 2022, down 45% quarter-over-quarter.
  • 17 funds opened new Celularity positions in Q4 2022 and 15 closed out, a net change of +2 holders.
  • The largest Celularity buyer in Q4 2022 was State Street, an estimated $375K added.
  • The largest Celularity seller in Q4 2022 was B. Riley Financial, an estimated $870K sold.

Based on aggregated 13F filings for Q4 2022.